Korean treatment recommendations for patients with axial ...

Korean treatment recommendations for patients with axial ... - PubMed

Recommendations 1 and 2 pertain to treatment strategies, regular disease status assessment, and rheumatologist-steered multidisciplinary management.

In Korea, biological agents, including TNF inhibitors such as etarnercept, infliximab, adalimumab, and golimumab, and IL-17 inhibitors such as ...

Korean treatment recommendations for patients with axial ...

Recommendation 1. We recommend that the treatment of axSpA should be tailored for each patient using regular assessments of their clinical state and disease ...

Korean treatment recommendations for patients with axial ...

Korean treatment recommendations for patients with axial spondyloarthritis. Mi Ryoung Seo, M.D.1, Jina Yeo, M.D.1, Jun Won Park, M.D.2, Yeon ...

Korean treatment recommendations for patients with axial ...

These are intended to guide best practice in the treat- ment of axSpA. Keywords: Axial spondyloarthritis, Ankylosing spondylitis, Treatment, ...

Korean treatment recommendations for patients with axial ...

We aimed to develop evidence-based recommendations for treating axial spondylarthritis (axSpA) in Korea. The development committee was constructed, ...

Korean treatment recommendations for patients with axial ...

Recommendations 18 and 19 pertain to total hip arthroplasty and spinal surgery. Monitoring of comorbidities and drug toxicities are recommended ...

Korean treatment recommendations for patients with axial ... - BVS

Recommendations 5-12 address pharmacological treatment of active disease using nonsteroidal anti-inflammatory drugs, glucocorticoids, sulfasalazine, biologics, ...

(PDF) Korean treatment recommendations for patients with axial ...

PDF | On Nov 10, 2023, Mi Ryoung Seo and others published Korean treatment recommendations for patients with axial spondyloarthritis | Find, ...

Corrigendum - The Korean Journal of Internal Medicine

The Evidence for Acupuncture Treatment in Axial Spondyloarthritis ...

In this sense, including CM such as spa treatments and acupuncture (which are commonly used by AxSpA patients), in the Clinical Practice Guidelines (CPG) in ...

Korean treatment recommendations for patients with axial ...

In the article “Korean treatment recommendations for patients with axial spondyloarthritis” by Seo MR et al. (Korean J Intern. Med 2023;38:620-640), there is ...

Corrigendum: Korean treatment recommendations for patients with ...

Corrigendum: Korean treatment recommendations for patients with axial spondyloarthritis · Open Access · Creative Commons Attribution Non-Commercial License.

Pan American League of Associations for Rheumatology ... - Nature

In patients with axSpA with purely axial involvement that is active despite treatment with NSAIDs, treatment with sulfasalazine, methotrexate or ...

A New Medical Therapy for Axial Spondyloarthritis

However, in axSpA patients, ustekinumab effectiveness was low and a phase 3 clinical trial was terminated. The anti-IL-17A monoclonal antibody ...

Remission in axial spondyloarthritis: Developing a consensus ...

2024, Rheumatology and Therapy. Korean treatment recommendations for patients with axial spondyloarthritis. 2023, Korean Journal of Internal Medicine. View ...

Axial Spondyloarthritis Treatment Recommendations and Disease ...

... Korean; Kurdish ... Conclusion Treatment guidelines are an important resource for rheumatologists who manage patients with axSpA/AS.

Canadian Rheumatology Association/Spondyloarthritis Research ...

Objective To provide a set of living treatment recommendations that will provide contemporary guidance on the management of patients with axial ...

Axial Spondyloarthritis | RINVOQ® (upadacitinib)

Treatment with RINVOQ is not recommended in patients with an ALC <500 cells/mm3. Evaluate at baseline and thereafter according to routine patient management.

Understanding Axial Spondyloarthritis: A Primer for Managed Care

Nonsteroidal anti-inflammatory drugs (NSAIDs) and physical therapy are strongly recommended as first-line management strategies for patients ...